Skip to main content

Dr. Vivek Sharma, MD

Hematology & Oncology (Hematology & Oncology Physician)

  • Medicare participating

At a glance

Years since graduation
34
In the NPI registry since
2006
Medicare patients seen, 2024
189

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Hematology & Oncology Physician primary
    KY license 34402

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Hematology & Oncology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
189
Services billed
552
Patients’ average age
71
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 30-39 minutes501152
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes4122
New patient office or other outpatient visit, 60-74 minutes2222
Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes1413
Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes1412

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 23 companies reported 190 payments worth $164,663 in total to this clinician.

By type
Compensation for services other than consulting (speaking, faculty)$136,458
Travel and Lodging$16,775
Consulting Fee$7,166
Food and Beverage$4,171
Education$93.53

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Aug 28, 2025Genzyme Corporation
Aug 28, 2025
Compensation for services other than consulting (speaking, faculty)
CABLIVI · Hematology
$10,388
Feb 27, 2025Genzyme Corporation
Feb 27, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$10,388
Apr 5, 2025Genzyme Corporation
Apr 5, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$10,388
May 23, 2025Genzyme Corporation
May 23, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$10,388
Apr 23, 2025Genzyme Corporation
Apr 23, 2025
Compensation for services other than consulting (speaking, faculty)
CABLIVI · Hematology
$8,726
Sep 16, 2025Novo Nordisk Inc
Sep 16, 2025
Compensation for services other than consulting (speaking, faculty)
NovoSeven · Hemophilia
$6,714
Aug 15, 2025Novo Nordisk Inc
Aug 15, 2025
Compensation for services other than consulting (speaking, faculty)$6,550
Oct 2, 2025Pfizer Inc.
Oct 2, 2025
Consulting Fee
HYMPAVZI · IMMUNOLOGY
$6,325
Oct 23, 2025Novo Nordisk Inc
Oct 23, 2025
Compensation for services other than consulting (speaking, faculty)
Alhemo · Hemophilia
$5,731
Jun 5, 2025Novo Nordisk Inc
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
Alhemo · Hemophilia
$5,404
All 75 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 3, 2025Genzyme Corporation
Dec 3, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$2,909
Nov 20, 2025Genzyme Corporation
Nov 20, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$2,909
Nov 13, 2025Pfizer Inc.
Nov 13, 2025
Compensation for services other than consulting (speaking, faculty)
HYMPAVZI · IMMUNOLOGY
$3,125
Nov 7, 2025Genzyme Corporation
Nov 7, 2025
Consulting Fee
QFITLIA
$841
Oct 29, 2025Novo Nordisk Inc
Oct 29, 2025
Compensation for services other than consulting (speaking, faculty)
Alhemo · Hemophilia
$4,421
Oct 29, 2025AstraZeneca Pharmaceuticals LP
Oct 29, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$3,280
Oct 29, 2025Novo Nordisk Inc
Oct 29, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Lexington, KY · in-kind
$749
Oct 23, 2025Novo Nordisk Inc
Oct 23, 2025
Compensation for services other than consulting (speaking, faculty)
Alhemo · Hemophilia
$5,731
Oct 23, 2025Novo Nordisk Inc
Oct 23, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Richmond, VA · in-kind
$550
Oct 23, 2025Novo Nordisk Inc
Oct 23, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Richmond, VA · in-kind
$207
Oct 23, 2025AstraZeneca Pharmaceuticals LP
Oct 23, 2025
Travel and Lodging
travel to Louisville, KY
$63.98
Oct 23, 2025Novo Nordisk Inc
Oct 23, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Richmond, VA · in-kind
$40.31
Oct 16, 2025Pfizer Inc.
Oct 16, 2025
Travel and Lodging
HYMPAVZI · IMMUNOLOGY · travel to Miami, FL · in-kind
$230
Oct 16, 2025Pfizer Inc.
Oct 16, 2025
Travel and Lodging
HYMPAVZI · IMMUNOLOGY · travel to Miami, FL · in-kind
$60.06
Oct 16, 2025Pfizer Inc.
Oct 16, 2025
Travel and Lodging
HYMPAVZI · IMMUNOLOGY · travel to Miami, FL · in-kind
$30.00
Oct 15, 2025Pfizer Inc.
Oct 15, 2025
Travel and Lodging
HYMPAVZI · IMMUNOLOGY · travel to Cincinnati, OH · in-kind
$927
Oct 15, 2025Pfizer Inc.
Oct 15, 2025
Travel and Lodging
HYMPAVZI · IMMUNOLOGY · travel to Miami, FL · in-kind
$708
Oct 10, 2025Pfizer Inc.
Oct 10, 2025
Compensation for services other than consulting (speaking, faculty)
HYMPAVZI · IMMUNOLOGY
$4,250
Oct 7, 2025Pfizer Inc.
Oct 7, 2025
Compensation for services other than consulting (speaking, faculty)
HYMPAVZI · IMMUNOLOGY
$4,625
Oct 2, 2025Pfizer Inc.
Oct 2, 2025
Consulting Fee
HYMPAVZI · IMMUNOLOGY
$6,325
Oct 2, 2025Pfizer Inc.
Oct 2, 2025
Compensation for services other than consulting (speaking, faculty)
HYMPAVZI · IMMUNOLOGY
$40.00
Sep 23, 2025Pfizer Inc.
Sep 23, 2025
Travel and Lodging
HYMPAVZI · IMMUNOLOGY · travel to Miami, FL · in-kind
$247
Sep 18, 2025Genzyme Corporation
Sep 18, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$1,662
Sep 16, 2025Novo Nordisk Inc
Sep 16, 2025
Compensation for services other than consulting (speaking, faculty)
NovoSeven · Hemophilia
$6,714
Sep 16, 2025Novo Nordisk Inc
Sep 16, 2025
Travel and Lodging
NovoSeven · Hemophilia · travel to Evansville, IN · in-kind
$902
Sep 11, 2025Genzyme Corporation
Sep 11, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$2,966
Sep 11, 2025Genzyme Corporation
Sep 11, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$2,966
Aug 28, 2025Genzyme Corporation
Aug 28, 2025
Compensation for services other than consulting (speaking, faculty)
CABLIVI · Hematology
$10,388
Aug 28, 2025Genzyme Corporation
Aug 28, 2025
Travel and Lodging
CABLIVI · Hematology · travel to Charleston, SC · in-kind
$705
Aug 28, 2025Genzyme Corporation
Aug 28, 2025
Travel and Lodging
CABLIVI · Hematology · travel to Charleston, SC · in-kind
$509
Aug 28, 2025Genzyme Corporation
Aug 28, 2025
Travel and Lodging
CABLIVI · Hematology · travel to Charleston, SC
$190
Aug 28, 2025Genzyme Corporation
Aug 28, 2025
Travel and Lodging
CABLIVI · Hematology · travel to Charleston, SC · in-kind
$164
Aug 28, 2025Genzyme Corporation
Aug 28, 2025
Travel and Lodging
CABLIVI · Hematology · travel to Charleston, SC
$26.00
Aug 26, 2025Pfizer Inc.
Aug 26, 2025
Compensation for services other than consulting (speaking, faculty)
HYMPAVZI · IMMUNOLOGY
$3,125
Aug 15, 2025Novo Nordisk Inc
Aug 15, 2025
Compensation for services other than consulting (speaking, faculty)$6,550
Aug 15, 2025Novo Nordisk Inc
Aug 15, 2025
Travel and Lodging
travel to Philadelphia, PA · in-kind
$546
Aug 15, 2025Novo Nordisk Inc
Aug 15, 2025
Travel and Lodging
travel to Philadelphia, PA · in-kind
$394
Aug 15, 2025Novo Nordisk Inc
Aug 15, 2025
Travel and Lodging
travel to Philadelphia, PA · in-kind
$220
Jul 29, 2025AstraZeneca Pharmaceuticals LP
Jul 29, 2025
Education
IMFINZI · Oncology · in-kind
Company’s descriptionJournal Article
$68.49
Jun 30, 2025Pfizer Inc.
Jun 30, 2025
Compensation for services other than consulting (speaking, faculty)
HYMPAVZI · IMMUNOLOGY
$3,125
Jun 19, 2025AstraZeneca Pharmaceuticals LP
Jun 19, 2025
Compensation for services other than consulting (speaking, faculty)
Company’s descriptionSpeaker Fee
$1,640
Jun 18, 2025Novo Nordisk Inc
Jun 18, 2025
Compensation for services other than consulting (speaking, faculty)$835
Jun 16, 2025Genzyme Corporation
Jun 16, 2025
Compensation for services other than consulting (speaking, faculty)
CABLIVI · Hematology
$831
Jun 5, 2025Novo Nordisk Inc
Jun 5, 2025
Compensation for services other than consulting (speaking, faculty)
Alhemo · Hemophilia
$5,404
Jun 5, 2025Novo Nordisk Inc
Jun 5, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Birmingham, MI · in-kind
$1,451
Jun 5, 2025Novo Nordisk Inc
Jun 5, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Birmingham, MI · in-kind
$655
Jun 5, 2025Novo Nordisk Inc
Jun 5, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Birmingham, MI · in-kind
$198
Jun 3, 2025Novo Nordisk Inc
Jun 3, 2025
Compensation for services other than consulting (speaking, faculty)
Alhemo · Hemophilia
$5,076
Jun 3, 2025Novo Nordisk Inc
Jun 3, 2025
Travel and Lodging
Alhemo · Hemophilia · travel to Cincinnati, OH · in-kind
$753
May 23, 2025Genzyme Corporation
May 23, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$10,388
May 23, 2025Genzyme Corporation
May 23, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$3,740
May 23, 2025Genzyme Corporation
May 23, 2025
Travel and Lodging
QFITLIA · Hematology · travel to Lubbock, TX · in-kind
$917
May 23, 2025Genzyme Corporation
May 23, 2025
Travel and Lodging
QFITLIA · Hematology · travel to Lubbock, TX · in-kind
$581
May 23, 2025Genzyme Corporation
May 23, 2025
Travel and Lodging
QFITLIA · Hematology · travel to Lubbock, TX · in-kind
$276
May 23, 2025Genzyme Corporation
May 23, 2025
Travel and Lodging
QFITLIA · Hematology · travel to Lubbock, TX
$40.00
May 23, 2025Genzyme Corporation
May 23, 2025
Travel and Lodging
QFITLIA · Hematology · travel to Lubbock, TX
$15.73
May 21, 2025Genzyme Corporation
May 21, 2025
Compensation for services other than consulting (speaking, faculty)
QFITLIA · Hematology
$2,909
May 20, 2025Genentech, Inc.
May 20, 2025
Education
Hemlibra · Hematology
$25.04
Apr 23, 2025Genzyme Corporation
Apr 23, 2025
Compensation for services other than consulting (speaking, faculty)
CABLIVI · Hematology
$8,726
Apr 23, 2025Genzyme Corporation
Apr 23, 2025
Travel and Lodging
CABLIVI · Hematology · travel to Fort Wayne, IN · in-kind
$1,408
Apr 5, 2025Genzyme Corporation
Apr 5, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$10,388
Apr 5, 2025Genzyme Corporation
Apr 5, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Richardson, TX · in-kind
$784
Apr 5, 2025Genzyme Corporation
Apr 5, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Richardson, TX · in-kind
$310
Apr 5, 2025Genzyme Corporation
Apr 5, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Richardson, TX · in-kind
$111
Apr 2, 2025Genzyme Corporation
Apr 2, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$3,324
Mar 13, 2025Novo Nordisk Inc
Mar 13, 2025
Compensation for services other than consulting (speaking, faculty)$139
Mar 11, 2025Novo Nordisk Inc
Mar 11, 2025
Compensation for services other than consulting (speaking, faculty)$418
Mar 11, 2025Novo Nordisk Inc
Mar 11, 2025
Compensation for services other than consulting (speaking, faculty)$278
Mar 11, 2025Novo Nordisk Inc
Mar 11, 2025
Compensation for services other than consulting (speaking, faculty)$278
Feb 27, 2025Genzyme Corporation
Feb 27, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$10,388
Feb 27, 2025Genzyme Corporation
Feb 27, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Lubbock, TX · in-kind
$824
Feb 27, 2025Genzyme Corporation
Feb 27, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Lubbock, TX · in-kind
$797
Feb 27, 2025Genzyme Corporation
Feb 27, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Lubbock, TX · in-kind
$159
Feb 27, 2025Genzyme Corporation
Feb 27, 2025
Travel and Lodging
ALTUVIIIO · Hematology · travel to Lubbock, TX
$28.00
Feb 19, 2025Genzyme Corporation
Feb 19, 2025
Compensation for services other than consulting (speaking, faculty)
ALTUVIIIO · Hematology
$2,909

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Kentucky →

Industry-funded research

Named as a principal investigator on 8 industry-funded studies in 2025, from 7 companies. The companies reported $104,837 in research payments for these studies, mostly to the institutions running them.

  • A Phase 3, Randomized Study to Evaluate the Efficacy and Safety of Pembrolizumab MK-3475 Lenvatinib E7080,MK-7902 Chemotherapy Compared with Standard of Care as First-line Intervention in Participants with Metastati…
    Merck Sharp & Dohme LLC
  • A Multicenter, Open-label, Phase 3 Study to Evaluate the Long-term Safety and Efficacy in Participants who are Currently on Treatment or in Follow-up in Studies That Include Pembrolizumab
    Merck Sharp & Dohme LLC
  • BMN 270-401
    BioMarin Pharmaceutical Inc.
  • Durvalumab or Placebo in Combination With Gemcitabine Cisplatin in Patients With 1st Line Advanced Biliary Tract Cancer TOPAZ-1
    AstraZeneca Pharmaceuticals LP
  • An Open Label, Multicenter, Rollover Study to Enable Continued Treatment Access for Subjects Previously Enrolled in Studies of Ruxolitinib
    Incyte Corporation
  • Phase I open-label, dose escalation trial of BI 1831169 monotherapy and in combination with an anti-PD-1 mAb in patients with advanced or metastatic solid tumors
    Boehringer Ingelheim Pharma GmbH & Co.kg
  • Phase I open-label, dose escalation trial of BI 1831169 monotherapy and in combination with an anti-PD-1 mAb in patients with advanced or metastatic solid tumors
    Boehringer Ingelheim Pharmaceuticals, Inc.
  • MRD Monotherapy, combination of VSV-GP w/ antiPD1
    Boehringer Ingelheim International GmbH

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Hematology & Oncology clinicians in Louisville

Sources

NPI registry (CMS NPPES, November 2026; record last updated May 20, 2010), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1144209982. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.